Filter
1256
Text search:
drug
susceptibility
Featured
Recommendations
155
New Publications
301
Language
Document type
No document type
682
Studies & Reports
221
Guidelines
210
Manuals
59
Strategic & Response Plan
37
Fact sheets
20
Training Material
14
Situation Updates
10
Online Courses
2
Infographics
1
Countries / Regions
India
63
Western and Central Europe
43
Ethiopia
32
Eastern Europe
31
Kenya
28
Global
27
South Africa
26
Latin America and the Carribbean
24
Tanzania
21
Zambia
19
Nigeria
18
Nepal
18
Africa
18
Bangladesh
16
Uganda
14
Philippines
14
Malawi
13
Ghana
11
Rwanda
11
Asia
11
Liberia
10
Zimbabwe
10
Namibia
9
South–East Asia Region
9
Cambodia
8
Ukraine
8
Sierra Leone
7
Mozambique
6
Peru
6
Eswatini/ Swaziland
6
Russia
6
Pakistan
5
Botswana
5
Lesotho
5
Myanmar / Burma
5
Cameroon
4
Colombia
4
Western Pacific Region
4
Tajikistan
4
Vietnam
4
Burkina Faso
3
Senegal
3
Germany
3
Syria
3
Sudan
3
Brazil
3
Albania
3
Laos
3
Spain
3
Congo, Democratic Republic of
2
USA
2
Saudi Arabia
2
Iraq
2
Jordan
2
Afghanistan
2
Lebanon
2
Turkey
2
Thailand
2
Indonesia
2
Argentina
2
Ecuador
2
Sri Lanka
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
Fiji
2
Bhutan
2
Venezuela
2
Iran
2
Georgia
2
North America
2
Gabon
2
United Kingdom
2
Mali
1
Morocco
1
Haiti
1
Gambia
1
China
1
Ireland
1
Papua New Guinea
1
Benin
1
North Macedonia
1
El Salvador
1
Bolivia
1
Greece
1
Libya
1
East and Southern Africa
1
Armenia
1
Timor Leste/ East Timor
1
Qatar
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
390
Clinical Guidelines
152
Public Health
60
Women & Child Health
26
Key Resources
24
Pharmacy & Technologies
18
Capacity Building
16
Toolboxes
TB
361
AMR
186
HIV
107
NTDs
57
COVID-19
43
Mental Health
37
Malaria
26
Planetary Health
22
Rapid Response
21
Pharmacy
18
Ebola & Marburg
14
Refugee
14
Caregiver
12
Cholera
11
Polio
11
Global Health Education
11
NCDs
11
2.0 Rapid Response
9
Conflict
7
Natural Hazards
7
Specific Hazards
5
Disability
4
Zika
3
Health Financing Toolbox
1
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S
...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the
...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three
...
MSF Essential Drugs - Practical Guidelines 2022
recommended
Practical guide intended for physicians, pharmacists, nurses and medical auxiliaries. This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses and health auxiliaries invoved in curative care and
...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G
...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t
...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i
...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a
...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi
...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to
...
Tuberculosis (TB) is an infectious disease that usually affects the lungs, though it can affect any organ in the body. It can develop when bacteria spread through droplets in the air. TB can be fatal, but in many cases, TB is preventable and treatable. This report examines the human rights impact of
...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect
...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the
...
Rappart sur les populations clés.
